ZipDose® - How APRECIA PHARMACEUTICALS sees the future of high-dose medication

In 2015 Aprecia got their first 3D printed drug product approved by the FDA. The technology used to print an oral dose drug is called Powder-liquid three-dimensional printing (3DP) and was already developped in the late 1980’s at the Massachusetts Institute of Technology (MIT). The principle is simple: An aqueous fluid binds together multiple layers of powder in a layer-by-layer process. This new technology promises to enable delivery of high-dose medications in a rapidly disintegrating form.

[vc_row][vc_column][vc_column_text]

Is this the future of drug manufacturing?

[/vc_column_text][/vc_column][/vc_row]

ZipDose® - How APRECIA PHARMACEUTICALS sees the future of high-dose medication